Molecular serum signature of treatment resistant depression.

Psychopharmacology (Berl) 2016 Aug 20;233(15-16):3051-9. Epub 2016 Jun 20.

Department of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.

Rationale: A substantial number of patients suffering from major depressive disorder (MDD) do not respond to multiple trials of anti-depressants, develop a chronic course of disease and become treatment resistant. Most of the studies investigating molecular changes in treatment-resistant depression (TRD) have only examined a limited number of molecules and genes. Consequently, biomarkers associated with TRD are still lacking.

Objectives: This study aimed to use recently advanced high-throughput proteomic platforms to identify peripheral biomarkers of TRD defined by two staging models, the Thase and Rush staging model (TRM) and the Maudsley Staging Model (MSM).

Methods: Serum collected from an inpatient cohort of 65 individuals suffering from MDD was analysed using two different mass spectrometric-based platforms, label-free liquid chromatography mass spectrometry (LC-MS(E)) and selective reaction monitoring (SRM), as well as a multiplex bead based assay.

Results: In the LC-MS(E) analysis, proteins involved in the acute phase response and complement activation and coagulation were significantly different between the staging groups in both models. In the multiplex bead-based assay analysis TNF-α levels (log(odds) = -4.95, p = 0.045) were significantly different in the TRM comparison. Using SRM, significant changes of three apolipoproteins A-I (β = 0.029, p = 0.035), M (β = -0.017, p = 0.009) and F (β = -0.031, p = 0.024) were associated with the TRM but not the MSM.

Conclusion: Overall, our findings suggest that proteins, which are involved in immune and complement activation, may represent potential biomarkers that could be used by clinicians to identify high-risk patients. Nevertheless, given that the molecular changes between the staging groups were subtle, the results need to be interpreted cautiously.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00213-016-4348-0DOI Listing
August 2016

Publication Analysis

Top Keywords

molecular changes
8
staging model
8
proteins involved
8
staging groups
8
treatment resistant
8
complement activation
8
staging
5
reaction monitoring
4
monitoring srm
4
srm well
4
selective reaction
4
spectrometry lc-mse
4
chromatography mass
4
well multiplex
4
mass spectrometry
4
lc-mse selective
4
assayresults lc-mse
4
analysis proteins
4
involved acute
4
acute phase
4

Similar Publications